Epilepsy, a chronic neurological disorder characterized by recurrent seizures, affects over 65 million people worldwide. The management of epilepsy has witnessed significant advancements in recent years. This article provides a comprehensive update on these developments for healthcare professionals.
Advancements in neuroimaging technologies such as high-resolution MRI and PET scans have enhanced the identification of structural and functional abnormalities in epilepsy. Genomic testing has also emerged as a valuable diagnostic tool, enabling personalized treatment strategies based on individual genetic profiles.
Over the past decade, several new AEDs have been introduced, offering improved safety and efficacy profiles. These include lacosamide, perampanel, and brivaracetam. Furthermore, the development of long-acting injectable AEDs has improved treatment adherence and quality of life for patients.
Neuromodulation therapies such as vagus nerve stimulation (VNS), responsive neurostimulation (RNS), and deep brain stimulation (DBS) have shown promising results in drug-resistant epilepsy. These therapies offer an alternative treatment approach for patients who are not suitable candidates for epilepsy surgery.
Minimally invasive surgical techniques such as laser interstitial thermal therapy (LITT) and stereotactic radiosurgery (SRS) have revolutionized epilepsy surgery. These techniques offer significantly reduced morbidity and improved postoperative outcomes compared to traditional surgical methods.
The landscape of epilepsy management is rapidly evolving, with advancements in diagnostic tools, AEDs, neuromodulation therapies, and surgical techniques. These developments are paving the way towards personalized, efficient, and less invasive treatment strategies, improving the quality of life for individuals living with epilepsy. It is crucial for healthcare professionals to stay updated on these advancements to provide optimal care for their patients.
1.
Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.
2.
Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Radiation therapy can promote amphiregulin, which increases growth of metastases
5.
High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer
1.
Learning from Uncommon Inherited Bleeding Disorder Presentations
2.
Essential Strategies in Hematology for Healthcare Excellence
3.
An Overview Of Leukemia Cutis: What It Is And How To Treat It
4.
All About Ferric Gluconate – The Best Source Of Iron For Anemia
5.
Lymphomatoid Papulosis: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation